CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,743 shares (grant or award)
- 4 Grant or award Director acquired 3,166 shares (grant or award)
- 4 Grant or award Director acquired 1,073 shares (grant or award)
- 4 Grant or award Director acquired 1,835 shares (grant or award)
- 4 Grant or award Director acquired 2,418 shares (grant or award)
- 4 Grant or award Director acquired 4,391 shares (grant or award)
- 4 Grant or award Director acquired 1,489 shares (grant or award)
- 4 Grant or award Director acquired 2,545 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Grant or award Chief Financial Officer acquired 1,180 shares (grant or award)
- 4 Grant or award President & CEO acquired 413 shares (grant or award)
- 4 Grant or award Director acquired 1,642 shares (grant or award)
- 4 Grant or award Director acquired 2,905 shares (grant or award)
Page 12 of 37 · 739 filings